Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Apr 4, 2025

Accession no.
0001628280-25-016742
Filed
Apr 4, 2025
Trade date
Mar 3-31, 2025
Filing delay
32 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $880.9. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 3, 2025Common StockPPurchaseAcquired+10$5.54+$55.45,698,748Direct
Mar 4, 2025Common StockPPurchaseAcquired+10$5.11+$51.15,698,758Direct
Mar 5, 2025Common StockPPurchaseAcquired+10$6.75+$67.55,698,768Direct
Mar 6, 2025Common StockPPurchaseAcquired+10$6.57+$65.75,698,778Direct
Mar 7, 2025Common StockPPurchaseAcquired+10$6.51+$65.15,698,788Direct
Mar 10, 2025Common StockPPurchaseAcquired+7$5.85+$40.955,698,795Direct
Mar 11, 2025Common StockPPurchaseAcquired+7$4.85+$33.955,698,802Direct
Mar 12, 2025Common StockPPurchaseAcquired+7$5.17+$36.195,698,809Direct
Mar 13, 2025Common StockPPurchaseAcquired+7$5.47+$38.295,698,816Direct
Mar 14, 2025Common StockPPurchaseAcquired+7$5.38+$37.665,698,823Direct
Mar 17, 2025Common StockPPurchaseAcquired+7$5.41+$37.875,698,830Direct
Mar 18, 2025Common StockPPurchaseAcquired+7$5.12+$35.845,698,837Direct
Mar 19, 2025Common StockPPurchaseAcquired+7$5.41+$37.875,698,844Direct
Mar 20, 2025Common StockPPurchaseAcquired+7$5.07+$35.495,698,851Direct
Mar 21, 2025Common StockPPurchaseAcquired+7$4.89+$34.235,698,858Direct
Mar 24, 2025Common StockPPurchaseAcquired+8$4.42+$35.365,698,866Direct
Mar 25, 2025Common StockPPurchaseAcquired+8$4.45+$35.65,698,874Direct
Mar 26, 2025Common StockPPurchaseAcquired+8$4.41+$35.285,698,882Direct
Mar 27, 2025Common StockPPurchaseAcquired+8$4.20+$33.65,698,890Direct
Mar 28, 2025Common StockPPurchaseAcquired+8$4.20+$33.65,698,898Direct
Mar 31, 2025Common StockPPurchaseAcquired+8$4.29+$34.325,698,906Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)